Saturday 19 February 2022

Total Return tumbles back to just 61% overall


Covid Vaccine Stocks slip back to lowest point - a return of just 61% overall for all stocks. Every stock in the index lost ground this week except Immunity Bio.



 

Friday 18 February 2022

Broad-based sell-off to end the week - 24 stocks dropped.


Another broad-based sell-off with 24 stocks dropping and only three gaining.

The overall average was a significant loss of 3.2%.

The biggest loser was Generex falling 20%. Tonix dropped 8% and PDS dropped 7%. 

 

Thursday 17 February 2022

Unanimous Sell-off Down 5.5% on average overall


Devastating Unanimous Sell-OFF!! 

5.5% LOSS OVERALL. 

 

Tuesday 15 February 2022

Big broad-based gains for Covid Vaccine Stocks - Immunity Bio jumps 22%


Rocketing upwards on February 15. A real strong broad-based move upwards lead by Immunity Bio which moved up 22%. There were fully 24 winners and only three losers today. 

The next strongest gainers were Novavax and Vaxart with 9% gains.

Vir, Ocugen and VBI all picked up 7%. 



 

Monday 14 February 2022

Heavy selling to start the week - Big Three hit hard.

 


Heavy selling to start the week. Overall there was a loss of 3.5%. There were 22 stocks who lost ground and five that gained.

The big three took the biggest hit. Moderna fell just under 12%, Novavax fell 11% and BioNTech fell 10%. Arcturus fell 7%. 

CureVac, Vir, Sorrento and Tonix fell 6%. 

OncoSec and iBio picked up 5%. 

Saturday 12 February 2022

Covid Vaccine Stocks move moderately higher.


Covid Vaccine Stocks bounce off the lows of January with total returns edging up to 72%.

PDS jumps by 117% in total returns and into third spot.

 

Friday 11 February 2022

Week finishes with a 2.3% drop


Stocks close the week slipping another 2.3%. There were no double digit losses but only six that gained ground with 21 losers.

Adaptive lead on the downside with a loss of 8%. Inovio lost 6%. Emergent lead on the upside with a gain of 5%.



 

Tuesday 8 February 2022

Small loss of 1.8% overall - Novavax stumbles 12%


Stocks edged downward, falling 1.8% overall with 17 losers and nine winners.

Novavax lead on the way down with a 12%. BioNTech fell 7% and TNXP fell 6%.

IMV lead on the upside picking up just under 5%.

 

Monday 7 February 2022

Generex jumps by one half


Generex delivers one of the biggest gains in the Covid era with a 51% leap. 

This outsized gain generated a 3.6% overall gain. There were 22 winners today and five losers.

IMV picked up just under 8%, and Novavax is nearing a breakthrough of $100, closing at $94.80 after gaining 6%. 

 

Friday 4 February 2022

Moderate move up with a 1.9% gain - 22 stocks gain and 5 lose.


That makes two positive days in a row. Today it was a gain of 1.9% on average overall.

IMV lead the way up with a double digit gain with a 10% pick up.

PDS picked up 6% whilte iBio, Inovio and Adaptive all picked up 5%.



 

Thursday 3 February 2022

Moderately hard move to the downside - 3.4% Loss


Another quite hard blow with 3.4% loss overall. 

There were no double digit losses but fully 12 stocks dropped 5% or more.

Only Generex and Vir gained with the other 25 losing ground.

iBio continued its down hill slalom leading the way down the hill, losing 7%. PDS dropped just under 7%. 

CureVac seems to be headed to 0 with another 6% loss. Immunity Bio, IMV and Inovio all lost over 6%. 


 

Wednesday 2 February 2022

Blood-letting resumes after brief reprieve


After a reprieve of a few days and a couple really good days, the blood-letting resumed this Ground Hog Day.....

The overall average was a loss of 3.8%, notwithstanding and amazing gain by the seriously lagging Generex which picked up almost 16% today. 

There were no double digit losses, but a ton of big single digit losses, lead by VBI, Sorrento, Heat Bio and Inovio, all with losses of over 7%. 

 

Tuesday 1 February 2022

Modest move upwards with a gain of 1.9% overall. Ocugen up 9%.


A modestly positive day with a gain of 1.9% overall. 21 stocks gained ground with 5 losing.

The biggest gainer was Ocugen with a pick up of 9%. The biggest loser was IBio with a loss of just over 5%. 



 

Monday 31 January 2022

Explosion upwards. One of biggest days of all time with an 8.6% overall gain. Fully 10 stocks picked up more than 10%


What a day! Total Explosion upwards! This has building for a while. The overall gain was 8.6%. Every single stock moved up except Generex slipped 5% to a new low.

There are literally 10 stocks with more than 10% gains. The biggest gainer was hard bitten Arcturus which jumped over 17%. Sorrento picked up just under 17%. 

Ocugen and PDS picked up 14%. Novavax had a 13% gain.

 

Saturday 29 January 2022

Overall return slips further to 61%. BioNTech moves into 3rd

 




Top Ten continue to sag, but worst of selling seemed to stall with a strong Friday. BioNTech moves up to 3rd overall a strong 42% pick up in today return, far outpacing all others. PDS dropped 39% and into 4th overall.

Sorrento falls out of the top ten, replaced by Vaxart.

Friday 28 January 2022

Huge Bounce Back day - up 4.8% overall


Huge Bounce Back Day! Overall bounce was 4.8% on average with 25 stocks moving up and only two going down.

Novavax finally rebounded up 14%. Altimmune and PDS Bio went up 10% to arrest a horrific downdraft.  Vir jumped up just under 9%. 






 

Thursday 27 January 2022

Total Wash Out. One of the worst days ever. Average loss of 5.5% on average. Sorrento and Tonix falls more than 10%


A Total washout. Red Sea. Warren Buffet would never invest in these turds.

One of the worst days ever. Hard to believe it could be this bad for these stocks.

Imagine losing 5.5% on average after the hell this month has been already.

Sorrento and Tonix had double digit losses. 12 stocks had losses of over 5%. This day sucked.

 

Friday 21 January 2022

Dance the Limbo! CureVac down 14% - 4.5% sell off


How low can this go? After a pause with just painful losses, we move back to ugly downdraft losses. 

Covid Vaccine stocks slumped 4.5% overall with full 23 dropping and only four picking up ground. 

CureVac is racing to a penny stock with another 14% buckling to lead on the way down. 

NanoViricides took a 10% hit, Sorrento dipped 9%, GeoVax and Ocugen fell 8%, Tonix dipped 7% and Novavax, BioNTech and PDS dropped 6%.






 

Thursday 20 January 2022

Pain continues - 2.7% losses on average overall


No double digit losses, but another painful 2.7% loss overall. Fully seven stocks lost 5% or more.

Only EBS and Dynavax gained.

Tonix and IBio lead on the way down with losses in the 6.5% range.





 

Wednesday 19 January 2022

Another 2.4% loss overall. OncoSec hit with a double digit loss


Another 2.4% loss overall as brutality continues. OncoSec let on the downside with another 10% hit. It has had a not bad couple of weeks after a disastrous year.

Moderna and Ocugen fell 7%, while Novavax fell 6%, Vir tumbled 5% and with BioNTech not far behind fall 4.5%. 

There were only two gainers and three others that did nothing -- a major win in this hellscape.


 

Tuesday 18 January 2022

Irrational Overwrought Hatred of Covid Vaccine Stocks Continue - 7.2% Loss on average




Devastating losses continue.

All but one stock wrecked today. Only little IMV managed a gain -- 5%.

The overall was a loss of 7.2%. Literally worst day of all time. 

Arcuturus cascaded downward--falling 19%! 

BioNTech buckled 14%. 

Novavax fell 11%.

Inovio collapsed to 10%.

EBS and NanoViricides were down just under 10%. 




Saturday 15 January 2022

Total Return just 101%. Every stock in top ten loses ground.


All ten lose ground as brutal winter 2022 wrecks havoc with Covid Vaccine Stocks. Novavax's return falls to 593% after giving back 108% return on the week.

Sorrento and Arcturus edge up a spot in the top ten because they lost less ground than their compatriots.

The Covid Vaccine Stocks have now slipped back to just 101% return overall. Gains blasted by the winter of '22.

 

Friday 14 January 2022

Finally some strength in the mid-sized group with GeoVax and CureVac whacked


A late afternoon bounce back by many mid-sized Covid Vaccine Stocks resulted in a gain overall with a pick up of 1.1%.

Weaklings of 2022, Aructurus, VBI and Immunity Bio, picked up 7% today.  Altimmune, Ocugen and Emergent picked up 6%. The three big boys all slipped again today with Novavax reaching all the way down to $110--losing half its value since Christmas.

There were 15 gainers with 11 losers. 

There were two particular losers: GeoVax down 11.5% and CureVac lost just under 10%. 


 

 

Thursday 13 January 2022

Heavy blow for Covid Vaccine Stocks with a loss of 3.5%. Novavax tumbles, Onco Sec bounces.

Really hard punch in the gut for COVID VACCINE STOCKS. 

On a day when the worst performer in 2021 (OncoSec) gains almost 14% and Novavax falls just under 14%, the overall hit was a 3.5%. There were 24 stocks that dropped with only three gaining grounds.

Adaptive slipped just under 9% and BioNTech tumbled 8%. 

 

Monday 10 January 2022

Big Boys had a strong day... Moderna and BioNTech up 9%


Moderna and BioNTech roared back with gains in the 9% range. Novavax picked up just under 7%.

Smaller names like Generex, Dynavax, Gritstone and Ocugen all had strong days in the 6% to 7% range.

Overall it was a positive day with a gain of 1.1% on average. There were 12 losers and 14 gainers. The biggest loser was VBI which dropped 8% to fall below $2 a share. Tonix and Adaptive both dropped 5%.

 

Saturday 8 January 2022

Covid Stocks limp downwards to lowest total return in almost two years. Moderna hit hardest.


Covid Vaccine stocks are down to just 113% return. This a low ebb - lowest since the very early days of the pandemic in the spring of 2021.

The big three also got hammered this week. 

On December 18, 2021, Novavax had a return of 1258%. It now sits at 701% for a drop of 557%. 

Moderna slipped 152% and BioNTech slipped 130 points. 

Sorrento was the only gainer in the TOP TEN which picked up 17% on the week 


Friday 7 January 2022

Stocks ease lower - just under 1% loss on average


Flat day with a tendency to ease lower - a fall of 0.9% loss overall on average.

There were 18 losers and nine gainers.

Generex which has continued under serious pressure with a loss of 5%. Altimmune and VBI lost just under 5%. 



 

Thursday 6 January 2022

Flat Day - 16 losers and 11 winners


Finally a boring flat day with minimal losses. The overall average was a loss of under 0.1%. There were 16 losers with 16 gainers.

Generex picked up just under 6% and Gritstone recovered just under 5% today. 

 

Wednesday 5 January 2022

ROYAL FLUSH.....right down the toilet



Another 6% collapse. 2 Days of THE END TIMES.

Novavax toboggans down 12% to lead on the downside. Arcturus and Generex also suffer double digit losses.

CureVac, Vir and Immunity cascade down 9%. 

Every stock lost ground. Not one broke even on this terrible day for these stocks.

 

Tuesday 4 January 2022

HELL DAY! Gritstone and NanoViricides wrecked


HELL DAY! 6% collapse. Worst day yet. Only IMV actually managed a gain.

Gritstone had positive sounding release about its "saMRNA" but go shellacked - losing almost half its value with a 42% drubbing.

NanoViricides also got pummeled - losing almost 13%. 

Heat Bio, PDS and Adaptive just missed a double digit loss, falling 9%. 



 

Saturday 1 January 2022

PDS Bio makes biggest move in 2021. OncoSec the worst


 

PDS Bio performed the best of all COVID VACCINE STOCKS, improving its overall return by 279% during 2021. The stock jumped from $2.14 to $8.10. 

OncoSec performed the worst, falling off a cliff, from $6.45 to $.96.

Interestingly, only 10 stocks improved their return during the teeth of the Covid Pandemic over the course of 2021. 

BioNTech and Dynavax improved their total return by 216% during the year.

Moderna ends year on top - red wave continues


Red Storm to end 2021. 

Novavax literally dropped 464 percentage points over the past two weeks of the year. It has fallen out of the number one spot. The year ends without a ten bagger. 

The overall return of the 27 stocks has dropped to its lowest point at a mere 137%.

Moderna has returned to the number one spot after picking up 15 in the last week and avoiding the selling scourge. 


 

Year ends on downer - stocks losing 2.6% overall on average


The last session of 2021 was back to the downside with a 2.6% loss on average overall.

The number 1 stock, Novavax, lead on the downside with a loss of just under 8%. Heat Biologics and NanoViricides fell 7%. Ocugen fell 6%, iBio, CureVac, Arcturus and Immunity Bio all dropped 5%. 

Twenty-two stocks of 27 lost ground.